MidWestOne Financial Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,127
| Closed | -$1.89M | – | 230 |
|
|
2020
Q4 | $1.89M | Buy |
12,127
+1,232
| +11% | +$192K | 0.52% | 41 |
|
|
2020
Q3 | $1.25M | Buy |
10,895
+1,548
| +17% | +$177K | 0.41% | 60 |
|
|
2020
Q2 | $1.05M | Buy |
9,347
+2,078
| +29% | +$233K | 0.44% | 41 |
|
|
2020
Q1 | $653K | Buy |
7,269
+1,537
| +27% | +$138K | 0.24% | 99 |
|
|
2019
Q4 | $619K | Buy |
5,732
+364
| +7% | +$39.3K | 0.13% | 131 |
|
|
2019
Q3 | $526K | Buy |
5,368
+371
| +7% | +$36.4K | 0.16% | 136 |
|
|
2019
Q2 | $655K | Buy |
+4,997
| New | +$655K | 0.18% | 138 |
|